Sublingual desmopressin is efficient and safe in the therapy of lithiasic renal colic
Authors:
- 16 December 2015
- journal article
- research article
- Published by Springer Nature in International Urology and Nephrology
- Vol. 48 (2) , 183-189
Abstract
To evaluate the effects of newer sublingual desmopressin administration in lithiasic renal colic, alone or combined with a nonsteroidal anti-inflammatory drug (NSAID). Prospective single-blind study including an initial number of 249 patients with lithiasic renal colic was randomized as follows: group NSAID (71 patients) received ketorolac tromethamine (ketorolac) 30 mg im and sublingual placebo (vitamin C), groups D1 and D2 (57 and 62 patients) received sublingual desmopressin (Minirin Melt), 60 and 120 μg, respectively, whereas group C (59 patients) received a combination of 30 mg im ketorolac and 60 μg sublingual desmopressin. Pain intensity was assessed using the visual analogue scale before and thirty minutes after drug administration. Patients experiencing pain aggravation were rescued and excluded from the study. Dropout incidence was higher in the NSAID group than in the groups treated with desmopressin in monotherapy or combined with ketorolac (p < 0.05). Pain intensity was diminished at least as potently by the monotherapy with desmopressin and ketorolac. The higher dose of desmopressin and the combination therapy decreased pain intensity with 56 and 59 %, respectively, significantly more than the 47 % decrease obtained with ketorolac alone (p < 0.05 and p < 0.001). Mean pain decrease was higher in the combination group (C) than in the NSAID or D1 groups (p < 0.001 and p < 0.05, respectively), suggesting drug additivity. Patients did not experience severe side effects. Sublingual desmopressin is at least as potent as NSAID in the treatment of lithiasic renal colic. The combination of sublingual desmopressin and NSAID has additive analgesic effects.Keywords
This publication has 31 references indexed in Scilit:
- New insights into the dynamic regulation of water and acid-base balance by renal epithelial cellsAmerican Journal of Physiology-Cell Physiology, 2012
- Assessment of Clinical Efficacy of Intranasal Desmopressin Spray and Diclofenac Sodium Suppository in Treatment of Renal Colic Versus Diclofenac Sodium AloneUrology, 2010
- Arginine vasopressin antinociception in the rat nucleus raphe magnus is involved in the endogenous opiate peptide and serotonin systemPeptides, 2009
- An assessment of the clinical efficacy of intranasal desmopressin spray in the treatment of renal colicBJU International, 2001
- Treatment of Renal Colic by Desmopressin Intranasal Spray and Diclofenac SodiumJournal of Urology, 1995
- Oral indomethacin for acute renal colicThe American Journal of Emergency Medicine, 1991
- Effects of [1-desamino-8-D-arginine]vasopressin and papaverine on rabbit renal pelvisEuropean Journal of Pharmacology, 1990
- PROSTAGLANDIN SYNTHETASE INHIBITION WITH INDOMETHACIN RECTAL SUPPOSITORIES IN THE TREATMENT OF ACUTE AND CHRONIC URINARY CALCULUS OBSTRUCTIONClinical and Experimental Pharmacology and Physiology, 1986
- Methodological problems in the measurement of pain: A comparison between the verbal rating scale and the visual analogue scalePain, 1975
- Effects of Ca++ and Prostaglandin E1 on Vasopressin Activation of Renal Adenyl CyclaseJournal of Clinical Investigation, 1971